E-mail: info@norpen.org

NorPEN is a network of researchers with the purpose of facilitating research within the field of pharmacoepidemiology in the Nordic countries.

January 26, 2021

Publications

This list includes papers of the NorPEN members, where collaborators are from more than one Nordic country and are based on data or describe data from more than one Nordic country.

Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016
Højlund M, Pottegård A, Johnsen E, Kroken RA, Reutfors J, Munk-Jørgensen P, Correl CU
Br J Pharmacol 2019; 1-9, https://doi.org/10.1111/bcp.13945

Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006-2016: A study in the five Nordic countries, United States and Australia.
Cohen JM, Cesta CE, Furu K, Einarsdóttir K, Gissler M, Havard A, Hernandez-Diaz S, Huybrechts KF, Kieler H, Leinonen MK, Li J, Reutfors J, Schaffer A, Selmer R, Yu Y, Zoega H, Karlstad Ø.
Pharmacoepidemiol Drug Saf 2020; 1-10. doi: 10.1002/pds.5035.

Antipsychotic drug use in pregnancy: a multinational study from ten countries.
Reutfors J, Cesta CE, Cohen JM, Bateman BT, Brauer R, Einarsdóttir K, Engeland A, Furu K, Gissler M, Havard A, Hernandez-Diaz S, Huybrechts KF, Karlstad Ø, Leinonen MK, Li J, Man KCK, Pazzagli L, Schaffer A, Schink T, Wang Z, Yu Y, Zoega H, Bröms G.
Schizophr Res 2020 Apr 12; S0920-9964(20)30158-4.

Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden.
Bröms G, Kieler H, Ekbom A, Gissler M, Hellgren K, Lahesmaa-Korpinen AM, Pedersen L, Schmitt-Egenolf M, Sørensen HT, Granath F.
Pharmacoepidemiol Drug Saf 2020 Mar; 29(3):316-327.

Risk of adverse birth outcomes after maternal varenicline use: A population-based observational study in Denmark and Sweden.
Pedersen L, Petronis KR, Nørgaard M, Mo J, Frøslev T, Stephansson O, Granath F, Kieler H, Sørensen HT.
Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):94-102. doi: 10.1002/pds.4894. Epub2019 Nov 11. PubMed PMID: 31713302.

Antidiabetic Medication Use during Pregnancy: An International Utilization Study.
Cesta CE, Cohen JM, Pazzagli L, Bateman BT, Bröms G, Einarsdóttir K, Furu K, Havard A, Heino A, Hernandez-Diaz S, Huybrechts KF, Karlstad Ø, Kieler H, Li J, Leinonen MK, Løvdal Gulseth H, Tran D, Yu Y, Zoega H, Odsbu I.
BMJ Open Diabetes Res Care 2019; 7 (1): e000759.

Trends in antidepressant use among children and adolescents: a Scandinavian drug utilization study.
Wesselhoeft R, Jensen PB, Talati A, Reutfors J, Furu K, Strandberg-Larsen K, Damkier P, Pottegård A, Bliddal M.
Acta Psychiatr Scand 2019: 1-9 doi: 10.1111/acps.13116.

Trends in Use of Paracetamol in the Nordic Countries.
Wastesson JW, Martikainen JE, Zoega H, Schmidt M, Karlstad Ø, Pottegård A.
Basic & Clinical Pharmacology & Toxicology doi: 10.1111/bcpt.13003.

Nonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective
Kristensen KB, Karlstad Ø, Martikainen JE, Pottegård A, Wastesson JW, Zoega H, Schmidt M.
Pharmacotherapy 2019 doi: 10.1002/phar.2217.

Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016.
Højlund M, Pottegård A, Johnsen E.
Br J Clin Pharmacol. 2019;1-9. doi: 10.1111/bcp.13945.

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries.
Ueda P, Pasternak B, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Melbye M, Svanström H.
Diabetes Care. 2019 Jun;42(6):e92-e94. doi: 10.2337/dc18-2532.

Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study.
Wintzell V, Svanström H, Olén O, Melbye M, Ludvigsson JF, Pasternak B.
Lancet Child Adolesc Health. 2019 Mar;3(3):158-165. doi: 10.1016/S2352-4642(18)30401-2.

Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden.
Svanström H, Ueda P, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Pasternak B.
Lancet Diabetes Endocrinol. 2019 Feb;7(2):106-114. doi: 10.1016/S2213-8587(18)30320-6.

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.
Ueda P, Svanström H, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Pasternak B.
BMJ. 2018 Nov 14;363:k4365. doi: 10.1136/bmj.k4365.

Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death.
Pasternak B, Wintzell V, Furu K, Engeland A, Neovius M, Stephansson O.
JAMA. 2018 Jun 12;319(22):2333-2335. doi: 10.1001/jama.2018.6237.

Beta-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study.
Bateman BT, Heide-Jørgensen U, Einarsdóttir K, Engeland A, Furu K, Gissler M, Hernandez-Diaz S, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Selmer R, Huybrechts KF, Zoega H.
Ann Intern Med. 2018 Nov 20;169(10):665-673. doi: 10.7326/M18-0338. Epub 2018 Oct 16.
[PubMed]

Effect of Maternal Psoriasis on Pregnancy and Birth Outcomes: A Population-based Cohort Study from Denmark and Sweden.
Bröms G, Haerskjold A, Granath F, Kieler H, Pedersen L, Berglind IA.
Acta Derm Venereol. 2018 Aug 29;98(8):728-734. doi: 10.2340/00015555-2923.
[PubMed]

Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.
Huybrechts KF, Bröms G, Christensen LB, Einarsdóttir K, Engeland A, Furu K, Gissler M, Hernandez-Diaz S, Karlsson P, Karlstad Ø, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Sørensen HT, Zoega H, Bateman BT.
JAMA Psychiatry. 2018 Feb 1;75(2):167-175. doi: 10.1001/jamapsychiatry.2017.3644.
[PubMed]

Data Resource Profile: The Nordic Obesity Surgery Cohort (NordOSCo).
Tao W, Artama M, von Euler-Chelpin M, Konings P, Ljung R, Lynge E, Ólafsdóttir GH, Pukkala E, Romundstad P, Tryggvadottir L, Wahlin K, Lagergren J.
Int J Epidemiol. 2017 Oct 10. doi: 10.1093/ije/dyx199.
[PubMed]

Cohort profile: the Nordic Antireflux Surgery Cohort (NordASCo).
Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, Euler-Chelpin MV, Lagergren J.
BMJ Open. 2017 Jun 8;7(6):e016505. doi: 10.1136/bmjopen-2017-016505.
[PubMed]

Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
Graner S, Svensson T, Beau AB, Damase-Michel C, Engeland A, Furu K, Hviid A, Håberg SE, Mølgaard-Nielsen D, Pasternak B, Kieler H.
BMJ. 2017 Feb 28;356:j629. doi: 10.1136/bmj.j629.
[PubMed]

Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.
Karlstad Ø, Zoëga H, Furu K, Bahmanyar S, Martikainen JE, Kieler H, Pottegård A.
Eur J Clin Pharmacol. 2016 Sep 1.
[PubMed]

Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: The Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy.
Selmer R, Haglund B, Furu K, Andersen M, Nørgaard M, Zoëga, H, Kieler H.
Pharmacoepidemiol Drug Saf. 2016 May 19. doi: 10.1002/pds.4033
[PubMed]

Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.
Zoega H, Kieler H, Nørgaard M, Furu K, Valdimarsdottir U, Brandt L, Haglund B.
PLoS One. 2015 Dec 14;10(12):e0144474. doi: 10.1371/journal.pone.0144474. eCollection 2015. PMID: 26657647
[PubMed]

Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir UA, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M.
BMJ. 2015 Apr 17;350:h1798. doi: 10.1136/bmj.h1798.
[PubMed] [PubMed Central]

Use of antidepressants and association with elective termination of pregnancy: population based case-control study.
Kieler H, Malm H, Artama M, Engeland A, Furu K, Gissler M, Nørgaard M, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B.
BJOG. 2014 Nov 14.
[PubMed]

Nordic databases to evaluate medications in pregnancy.
Kieler H.
Therapie. 2014 Jan-Feb;69(1):65-9. doi: 10.2515/therapie/2014009. Epub 2014 Apr 4.
[PubMed]

The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
Wettermark B, Zoëga H, Furu K, Korhonen M, Hallas J, Nørgaard M, Almarsdottir A, Andersen M, Andersson Sundell K, Bergman U, Helin-Salmivaara A, Hoffmann M, Kieler H, Martikainen J, Mortensen M, Petzold M, Wallach-Kildemoes H, Wallin C, Sørensen H.
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):691-9. doi: 10.1002/pds.3457
[PubMed]

Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, Gissler M, Nørgaard M, Nielsen RB, Zoega H, Valdimarsdóttir U.
JAMA. 2013 Jan 2;309(1):48-54. doi: 10.1001/jama.2012.153812.
[PubMed]

Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, Nielsen RB, Nørgaard M, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B.
BMJ. 2012 Jan 12;344:d8012. doi: 10.1136/bmj.d8012.
[PubMed]

Use of lithium in the adult populations of Denmark, Norway and Sweden.
Bramness JG, Weitoft GR, Hallas J.
J Affect Disord. 2009 Nov;118(1-3):224-8. doi: 10.1016/j.jad.2009.01.024. Epub 2009 Feb 26.
[PubMed]

The Nordic countries as a cohort for pharmacoepidemiological research.
Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT.
Basic Clin Pharmacol Toxicol. 2010 Feb;106(2):86-94. doi:10.1111/j.1742-7843.2009.00494.x. Epub 2009 Dec 4. Review.
[PubMed]

SYMPOSIUM (6th NorpEN meeting): Research on drug safety and effectiveness using pharmacoepidemiological databases.
J Intern Med Volume 275, Issue 6, page 547, June 2014.
[PubMed]

Research on drug safety and effectiveness using pharmacoepidemiological databases.
M. Andersen
J Intern Med. 2014 Jun;275(6):548-50. doi: 10.1111/joim.12235
[PubMed]

Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
G. Trifirò, P. M. Coloma, P. R. Rijnbeek, S. Romio, B. Mosseveld, D. Weibel, J. Bonhoeffer, M. Schuemie, J. van der Lei and M. Sturkenboom.
J Intern Med. 2014 Jun;275(6):551-61. doi: 10.1111/joim.12159
[PubMed]

Use of electronic healthcare records in large-scale simple randomized trials at the point of care for the documentation of value-based medicine.
van Staa TP, Klungel O, Smeeth L.
J Intern Med. 2014 Jun;275(6):562-9. doi: 10.1111/joim.12211.
[PubMed]

Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs.
Stürmer T, Wyss R, Glynn RJ, Brookhart MA.
J Intern Med. 2014 Jun;275(6):570-80. doi: 10.1111/joim.12197. Epub 2014 Feb 13.
[PubMed] [PubMed Central]

Use of self-controlled designs in pharmacoepidemiology.
Hallas J, Pottegård A.
J Intern Med. 2014 Mar 17. (Epub)
[PubMed]

Application of routine electronic health record databases for pharmacogenetic research.
Yasmina A, Deneer VH, Maitland-van der Zee AH, van Staa TP, de Boer A, Klungel OH.
J Intern Med. 2014 Jun;275(6):590-604. doi: 10.1111/joim.12226.
[PubMed]